Hexamer; Laura A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hexamer; Laura A..The latest application filed is for "bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases".

Company Profile

0.15.12

Hexamer; Laura A. - Grayslake IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,315,488 - Ding , et al. April 19, 2	2016-04-19
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20160009687 - Ding; Hong ; et al.	2016-01-14
Apoptosis-inducing Agent For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20160002187 - Kunzer; Aaron R. ; et al.	2016-01-07
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,156,856 - Kunzer , et al. October 13, 2	2015-10-13
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,125,913 - Bruncko , et al. September 8, 2	2015-09-08
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,072,748 - Bruncko , et al. July 7, 2	2015-07-07
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,045,420 - Doherty , et al. June 2, 2	2015-06-02
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,029,404 - Doherty , et al. May 12, 2	2015-05-12
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140107119 - Bruncko; Milan ; et al.	2014-04-17
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140088106 - Bruncko; Milan ; et al.	2014-03-27
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057890 - Bruncko; Milan ; et al.	2014-02-27
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057889 - Bruncko; Milan ; et al.	2014-02-27
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,557,983 - Doherty , et al. October 15, 2	2013-10-15
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,426,422 - Hexamer , et al. April 23, 2	2013-04-23
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,343,967 - Ding , et al. January 1, 2	2013-01-01
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,338,466 - Kunzer , et al. December 25, 2	2012-12-25
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20120214796 - Ding; Hong ; et al.	2012-08-23
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,188,077 - Ding , et al. May 29, 2	2012-05-29
Substituted thieno[3,2-d]pyrimidine PIM kinase inhibitors as cancer chemotherapeutics Grant 8,148,384 - Penning , et al. April 3, 2	2012-04-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20110237553 - Ding; Hong ; et al.	2011-09-29
Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases Grant 7,956,185 - Diebold , et al. June 7, 2	2011-06-07
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100184766 - Kunzer; Aaron R. ; et al.	2010-07-22
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100184750 - Hexamer; Laura A. ; et al.	2010-07-22
Pim Kinase Inhibitors As Cancer Chemotherapeutics App 20080161559 - Penning; Thomas D. ; et al.	2008-07-03
Inhibitors Of Polo-like Kinases App 20080015192 - Diebold; Robert B. ; et al.	2008-01-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.